| Literature DB >> 28205590 |
Joana R Almeida1, Marta Correia-da-Silva1,2, Emília Sousa1,2, Jorge Antunes1,3, Madalena Pinto1,2, Vitor Vasconcelos1,3, Isabel Cunha1.
Abstract
Natural products with a sulfated scaffold have emerged as antifouling agents with low or nontoxic effects to the environment. In this study 13 sulfated polyphenols were synthesized and tested for antifouling potential using the anti-settlement activity of mussel (Mytilus galloprovincialis) plantigrade post-larvae and bacterial growth inhibition towards four biofilm-forming bacterial strains. Results show that some of these Nature-inspired compounds were bioactive, particularly rutin persulfate (2), 3,6-bis(β-D-glucopyranosyl) xanthone persulfate (6), and gallic acid persulfate (12) against the settlement of plantigrades. The chemical precursors of sulfated compounds 2 and 12 were also tested for anti-settlement activity and it was possible to conclude that bioactivity is associated with sulfation. While compound 12 showed the most promising anti-settlement activity (EC50 = 8.95 μg.mL-1), compound 2 also caused the higher level of growth inhibition in bacteria Vibrio harveyi (EC20 = 12.5 μg.mL-1). All the three bioactive compounds 2, 6, and 12 were also found to be nontoxic to the non target species Artemia salina (<10% mortality at 250 μM) and Vibrio fischeri (LC50 > 1000 μg.mL-1). This study put forward the relevance of synthesizing non-natural sulfated small molecules to generate new nontoxic antifouling agents.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28205590 PMCID: PMC5304334 DOI: 10.1038/srep42424
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Sulfated compounds chemical structures.
1, diosmin 2″,2″′,3″,3″′,4″,4″′-hexasulfate; 2, rutin 2″,2″′,3′,3″,3″′,4′,4″,4″′,7-nonasulfate; 3, 3″,4″-bis(2-sulfate ethoxy)-7-(2-sulfate ethoxy)-rutin 2″,2″′,3′,3″′,4′,4″′,7-sulfate; 4, 3,7-di(β-D-glucopyranosyl)flavone persulfate; 5, mangiferin 2′,3,3′,4′,6,6′,7-heptasulfate; 6, 3,6-bis(β-D-glucopyranosyl)xanthone persulfate; 7, 3,6-bis(1-(1-(β-D-galatopyranosyl)-1H-1,2,3-triazole-4-yl)methoxy)xanthone persulfate; 8, trans-resveratrol 3-β-D-glucopyranoside persulfate; 9, salicin persulfate; 10, 4-methylumbelliferyl 7-β-D-glucopyranoside persulfate; 11, 4-methylumbelliferyl 7-β-D-galactopyranoside persulfate; 12, gallic acid persulfate; 13, chlorogenic acid persulfate.
Figure 2Anti-settlement activity of sulfated compounds 1–13 towards plantigrades of the mussel Mytilus galloprovincialis.
*Indicates significant differences (p < 0.05, Dunnett test) against the negative control (B: ultra-pure water); CuSO4 at 5 μM was used as positive control (C).
Figure 3Concentration-response of anti-settlement activity of the promising AF compounds 2, 6, and 12 towards plantigrades of the mussel Mytilus galloprovincialis.
*Indicates significant differences at p < 0.05 (Dunnett test) ** at p < 0.001 (Dunnett test), against the negative control (B: ultra-pure water); CuSO4 at 5 μM was used as positive control (C).
Antifouling effectiveness versus toxicity of sulfated compounds 2, 6, and 12 and the commercial AF compound ECONEA® towards the anti-settlement of mussel plantigrades.
| Compound | EC50 (μM; μg.mL−1) | LC50 (μM) | LC50/EC50 |
|---|---|---|---|
| 22.59 (95% CI: 15.50–35.36); 36.84 | >500 | >22.13 | |
| 23.19 (95% CI: 15.70–35.40); 31.74 | >500 | >21.56 | |
| 17.65 (95% CI: 9.46–32.86); 8.4 | >500 | >26.61 | |
| ECONEA® | 4.012 (95% CI: 0.38–9.54); 1.40 | 107.78 (95% CI: 83.61–144.04) | 26.86 |
EC50, minimum concentration that inhibited 50% of larval settlement; LC50, the median lethal dose; LC50/EC50, therapeutic ratio. Note: reference values for EC50 < 25 μg.mL−1 (U.S. Navy program) and therapeutic ratio (LC50/EC50) higher than 15.
Figure 4Antibacterial activity of sulfated compounds 1–13 towards four biofilm-forming marine bacteria Cobetia marina, Vibrio harveyi, Pseudoalteromonas atlantica and Halomonas aquamarina.
*Indicates significant diferences (p < 0.05, Dunnett test) against the negative control (B: ultra-pure water); penicilin-streptomycin-neomycin stabilized solution was used as positive control (C).
Figure 5Concentration-response of antibacterial activity of the promising AF compounds 2 and 4 towards Vibrio harveyi and Halomonas aquamarina, respectively.
*Indicates significant differences at p < 0.05 (Dunnett test) against the negative control (B: ultra-pure water); penicilin-streptomycin-neomycin stabilized solution was used as positive control (C).
Bacterial growth inhibition activities of compounds 2 and 4.
| Compound | EC20 (μM; μg.mL−1) | |
|---|---|---|
| 7.69 (95% CI: 2.3–17.4); 12.54 | >100 | |
| >100 | 42.3 (95% CI: 31.2–60.9); 51.22 | |
EC20, minimum concentration that inhibited 20% of bacterial growth.